A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cowan, Graeme J M ^a   Bockau, Ulrike ^b   Eleni Muus, Janna ^b   Aldag, Ingo ^b   Samuel, Kay ^c   Creasey, Alison M ^a   Hartmann, Marcus W W ^b   Cavanagh, David R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Cilian AG   (Germany)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CULTURE MEDIUM; DIMERIZATION; EPITOPE MAPPING; FEMALE; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; MOUSE; NONHUMAN; TETRAHYMENA THERMOPHILA;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIBODIES, PROTOZOAN; EPITOPE MAPPING; FEMALE; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MICE; PLASMODIUM FALCIPARUM; TETRAHYMENA THERMOPHILA; VACCINATION; VACCINE POTENCY;

EID: 84900298508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087198     Document Type: Article

References (74)

1. WHO (2011) Questions and Answers on Malaria Vaccine. Available: http://www.who.int/vaccine-research/diseases/malaria/malaria-vaccine-questions- and-answers-october-2011.pdf. Accessed 2013 Jun 3.
2. malERA Consultative Group on Vaccines (2011) A research agenda for malaria eradication: vaccines. 8: e1000398. Available: http://eutils.ncbi.nlm. nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21311586&retmode= ref&cmd=prlinks.
3. Hill AVS (2011) Vaccines against malaria. Philosophical transactions of the Royal Society of London Series B, Biological sciences 366: 2806-2814. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=21893544&retmode=ref&cmd=prlinks.
4. Crompton PD, Pierce SK, Miller LH (2010) Advances and challenges in malaria vaccine development. The Journal of clinical investigation 120: 4168-4178. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id =21123952&retmode=ref&cmd=prlinks.
5. Huckriede A, Bungener L, Veer ter W, Holtrop M, Daemen T, et al. (2003) Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity. Vaccine 21: 925-931. Available: http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12547604&retmode= ref&cmd=prlinks.
6. Milich DR, Hughes J, Jones J, Sällberg M, Phillips TR (2001) Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate. Vaccine 20: 771-788. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 11738741&retmode=ref&cmd=prlinks.
7. Victor ME, Bengtsson A, Andersen G, Bengtsson D, Lusingu JP, et al. (2010) Insect cells are superior to Escherichia coli in producing malaria proteins inducing IgG targeting PfEMP1 on infected erythrocytes. Malaria Journal 9: 325. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=21078147&retmode=ref&cmd=prlinks.
8. Stowers AW, Chen L-H, Zhang Y, Kennedy MC, Zou L, et al. (2002) A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 99: 339-344. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=11752405&retmode=ref&cmd=prlinks.
9. Lau OS, Ng DW-K, Chan WWL, Chang SP, Sun SSM (2010) Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant biotechnology journal 8: 994-1004. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/ elink.fcgi?dbfrom=pubmed&id=20444208&retmode=ref&cmd=prlinks.
10. Pollack Y, Katzen AL, Spira DT, Golenser J (1982) The genome of Plasmodium falciparum. I: DNA base composition. 10: 539-546. Available: http://eutils. ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 6278419&retmode=ref&cmd=prlinks.
11. Gardner MJ, Hall N, Fung E, White O, Berriman M, et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498-511. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=12368864&retmode=ref&cmd=prlinks.
12. Eisen JA, Coyne RS, Wu M, Wu D, Thiagarajan M, et al. (2006) Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote. 4: e286. Available: http://biology.plosjournals.org/perlserv/?request=get- document&doi=10.1371/journal.pbio.0040286&ct=1.
13. Hellenbroich D, Valley U, Ryll T, Wagner R, Tekkanat N, et al. (1999) Cultivation of Tetrahymena thermophila in a 1.5-m3 airlift bioreactor. 51: 447-455. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=10341428&retmode=ref&cmd=prlinks.
14. Kiy T, Tiedtke A (1992) Continuous high-cell-density fermentation of the ciliated protozoon Tetrahymena in a perfused bioreactor. 38: 141-146. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 1369137&retmode=ref&cmd=prlinks.
15. Jayaram J, Papoyan A, Bisharyan Y, Cassidy-Hanley D, Zhang X, et al. (2010) An Alternative Platform for Rapid Production of Effective Subunit Vaccines. BioPharm International Supplements. Available: http://www.biopharm international.com/biopharm/Vaccine +Manufacturing+Articles/An-Alternative- Platform-for-Rapid-Production-of-Ef/ArticleStandard/Article/detail/690797.
16. Gaertig J, Gao Y, Tishgarten T, Clark TG, Dickerson HW (1999) Surface display of a parasite antigen in the ciliate Tetrahymena thermophila. Nature Biotechnology 17: 462-465. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=10331805&retmode=ref&cmd=prlinks.
17. Peterson DS, Gao Y, Asokan K, Gaertig J (2002) The circumsporozoite protein of Plasmodium falciparum is expressed and localized to the cell surface in the free-living ciliate Tetrahymena thermophila. Molecular and biochemical parasitology 122: 119-126. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=12106865&retmode=ref&cmd=prlinks.
18. Weide T, Bockau U, Rave A, Herrmann L, Hartmann MWW (2007) A recombinase system facilitates cloning of expression cassettes in the ciliate Tetrahymena thermophila. BMC microbiology 7: 12. Available: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17328820&retmode=ref&cmd =prlinks.
19. Aldag I, Bockau U, Rossdorf J, Laarmann S, Raaben W, et al. (2011) Expression, secretion and surface display of a human alkaline phosphatase by the ciliate Tetrahymena thermophila. BMC biotechnology 11: 11. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 21281462&retmode=ref&cmd=prlinks.
20. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, et al. (2005) Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. The Journal of biological chemistry 280: 40169-40176. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=16203726&retmode=ref&cmd=prlinks.
21. Sanders PR, Cantin GT, Greenbaum DC, Gilson PR, Nebl T, et al. (2007) Identification of protein complexes in detergent-resistant membranes of Plasmodium falciparum schizonts. Molecular and biochemical parasitology 154: 148-157. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=17553576&retmode=ref&cmd=prlinks.
22. Tanabe K, Mackay M, Goman M, Scaife JG (1987) Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. Journal of molecular biology 195: 273-287. Available: http://linkinghub.elsevier.com/ retrieve/pii/0022283687906498.
23. Jiang G, Daubenberger C, Huber W, Matile H, Tanner M, et al. (2000) Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania. Acta Tropica 74: 51-61. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=10643908&retmode=ref&cmd=prlinks.
24. Miller LH, Roberts T, Shahabuddin M, McCutchan TF (1993) Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Molecular and biochemical parasitology 59: 1-14. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 8515771&retmode=ref&cmd=prlinks.
25. Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JAL, Theander TG, et al. (2004) Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infection and immunity 72: 6492-6502. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=15501780&retmode=ref&cmd=prlinks.
26. Mawili-Mboumba DP, Borrmann S, Cavanagh DR, McBride JS, Matsiegui P-B, et al. (2003) Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malaria. J Infect Dis 187: 1137-1141. Available: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12660928&retmode=ref&cmd= prlinks.
27. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, et al. (2009) Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness. Infection and immunity 77: 1165-1174. Available: http://iai.asm.org/cgi/doi/10.1128/IAI.01129-08.
28. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, et al. (2000) A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med 6: 689-692. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 10835687&retmode=ref&cmd=prlinks.
29. Polley SD, Tetteh KKA, Cavanagh DR, Pearce RJ, Lloyd JM, et al. (2003) Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infection and immunity 71: 1833-1842. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=12654798&retmode=ref&cmd=prlinks.
30. Galamo CD, Jafarshad A, Blanc C, Druilhe P (2009) Anti-MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition. J Infect Dis 199: 1151-1154. Available: http://www.journals.uchicago.edu/doi/abs/10.1086/597426.
31. Cowan GJM, Creasey AM, Dhanasarnsombut K, Thomas AW, Remarque EJ, et al. (2011) A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response. PLoS ONE 6: e26616. doi:10.1371/journal.pone.0026616.
32. Quakyi IA, Currier J, Fell A, Taylor DW, Roberts T, et al. (1994) Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. Journal of immunology (Baltimore, Md : 1950) 153: 2082-2092. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 8051413&retmode=ref&cmd=prlinks.
33. Parra M, Hui G, Johnson AH, Berzofsky JA, Roberts T, et al. (2000) Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1. Infection and immunity 68: 2685-2691. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=10768960&retmode=ref&cmd=prlinks.
34. Chitarra V, Holm I, Bentley GA, Pêtres S, Longacre S (1999) The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. Molecular cell 3: 457-464. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=10230398&retmode=ref&cmd=prlinks.
35. Pizarro JC, Chitarra V, Verger D, Holm I, Pêtres S, et al. (2003) Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. Journal of molecular biology 328: 1091-1103. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 12729744&retmode=ref&cmd=prlinks.
36. Morgan WD, Birdsall B, Frenkiel TA, Gradwell MG, Burghaus PA, et al. (1999) Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. Journal of molecular biology 289: 113-122. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=10339410&retmode=ref&cmd=prlinks.
37. Gaur D, Mayer D, Miller L (2004) Parasite ligand-host receptor interactions during invasion of erythrocytes by merozoites. International Journal for Parasitology 34: 1413-1429. Available: http://linkinghub.elsevier. com/retrieve/pii/S0020751904002152.
38. Moss DK, Remarque EJ, Faber BW, Cavanagh DR, Arnot DE, et al. (2012) Plasmodium falciparum 19-Kilodalton Merozoite Surface Protein 1 (MSP1)- Specific Antibodies That Interfere with Parasite Growth In Vitro Can Inhibit MSP1 Processing, Merozoite Invasion, and Intracellular Parasite Development. Infection and immunity 80: 1280-1287. Available: http://iai.asm.org/cgi/doi/10. 1128/IAI.05887-11.
39. Blackman MJ (1994) Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. Journal of Experimental Medicine 180: 389-393. Available: http://www.jem.org/cgi/doi/10.1084/jem.180.1.389.
40. Egan AF, Burghaus P, Druilhe P, Holder AA, Riley EM (1999) Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite immunology 21: 133-139. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=10205793&retmode=ref&cmd=prlinks.
41. Dodoo D, Aikins A, Asamoah Kusi K, Lamptey H, Remarque E, et al. (2008) Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malaria Journal 7: 142. Available: http://www.malariajournal.com/content/7/1/142.
42. Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, et al. (1996) Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173: 765-769. Available: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8627050&retmode=ref&cmd= prlinks.
43. Keitel WA, Kester KE, Atmar RL, White AC, Bond NH, et al. (1999) Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. Vaccine 18: 531-539. Available: http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10519944&retmode= ref&cmd=prlinks.
44. Ockenhouse CF, Angov E, Kester KE, Diggs C, Soisson L, et al. (2006) Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. Vaccine 24: 3009-3017. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 16356603&retmode=ref&cmd=prlinks.
45. Babon JJ, Morgan WD, Kelly G, Eccleston JF, Feeney J, et al. (2007) Structural studies on Plasmodium vivax merozoite surface protein-1. Molecular and biochemical parasitology 153: 31-40. Available: http://eutils.ncbi.nlm.nih. gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17343930&retmode= ref&cmd=prlinks.
46. Arnot DE, Cavanagh DR, Remarque EJ, Creasey AM, Sowa MPK, et al. (2008) Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodiumfalciparum. Clinical and vaccine immunology : CVI 15: 1345-1355. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/ elink.fcgi?dbfrom=pubmed&id=18550731&retmode=ref&cmd=prlinks.
47. Sauer B (1987) Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Molecular and cellular biology 7: 2087-2096. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=3037344&retmode=ref&cmd=prlinks.
48. Gaertig JJ, Gu LL, Hai BB, GorovskyMAM (1994) High frequency vector-mediated transformation and gene replacement in Tetrahymena. Nucleic acids research 22: 5391-5398. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=7816630&retmode=ref&cmd=prlinks.
49. Cassidy-Hanley D, Bowen J, Lee JH, Cole E, VerPlank LA, et al. (1997) Germline and somatic transformation of mating Tetrahymena thermophila by particle bombardment. Genetics 146: 135-147. Available: http://www.genetics.org/ cgi/reprint/146/1/135.
50. Gaertig J, Kapler G (2000) Transient and stable DNA transformation of Tetrahymena thermophila by electroporation. 62: 485-500. Available: http://www.ncbi.nlm.nih.gov/pubmed/10503213?dopt =abstract.
51. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685. Available: http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 5432063&retmode=ref&cmd=prlinks.
52. McBride JS, Newbold CI, Anand R (1985) Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. The Journal of experimental medicine 161: 160-180. Available: http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=2578540&retmode= ref&cmd=prlinks.
53. Burghaus PA, Holder AA (1994) Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Molecular and biochemical parasitology 64: 165-169. Available: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8078519&retmode=ref&cmd= prlinks.
54. Cavanagh DR, McBride JS (1997) Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Molecular and biochemical parasitology 85: 197-211. Available: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=9106193&retmode=ref&cmd= prlinks.
55. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM (1999) Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20: 601-605. doi:10.1002/(SICI)1522-2683(19990301)20:3,601::AID-ELPS601.3.0. CO;2-6. (Pubitemid 29183427)
56. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
57. Shang Y, Song X, Bowen J, Corstanje R, Gao Y, et al. (2002) A robust inducible-repressible promoter greatly facilitates gene knockouts, conditional expression, and overexpression of homologous and heterologous genes in Tetrahymena thermophila. Proceedings of the National Academy of Sciences of the United States of America 99: 3734-3739. Available: http://eutils.ncbi.nlm.nih. gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=11891286&retmode= ref&cmd=prlinks.
58. Weide T, Herrmann L, Bockau U, Niebur N, Aldag I, et al. (2006) Secretion of functional human enzymes by Tetrahymena thermophila. 6: 19. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 16542419&retmode=ref&cmd=prlinks.
59. Turkewitz AP, Orias E, Kapler G (2002) Functional genomics: the coming of age for Tetrahymena thermophila. Trends in genetics : TIG 18: 35-40. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 11750699&retmode=ref&cmd=prlinks.
60. Blackman MJ, Whittle H, Holder AA (1991) Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Molecular and biochemical parasitology 49: 35-44. Available: http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=1723148&retmode= ref&cmd=prlinks.
61. Kocken CHM, Withers-Martinez C, Dubbeld MA, Van Der Wel A, Hackett F, et al. (2002) High-Level Expression of the Malaria Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte Invasion. Infection and immunity 70: 4471-4476. Available: http://iai.asm.org/cgi/doi/10.1128/IAI.70.8.4471-4476. 2002.
62. Gowda DC, Gupta P, Davidson EA (1997) Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum. The Journal of biological chemistry 272: 6428-6439. Available: http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=9045667&retmode=ref&cmd=prlinks.
63. Gowda DC, Davidson EA (1999) Protein glycosylation in the malaria parasite. Parasitology today (Personal ed) 15: 147-152. Available: http://www.sciencedirect.com/science?-ob=ArticleURL&-udi= B6TB8-3Y8687R-8&-user=809099&-rdoc=1&-fmt=&-orig= search&-sort=d&view=c&-acct=C000043939&-version= 1&-urlVersion=0&-userid=809099&md5=da54a5a92d2c9735bb2ac6e77ccc3768.
64. Garrity RR, Rimmelzwaan G, Minassian A, Tsai WP, Lin G, et al. (1997) Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. Journal of immunology (Baltimore, Md : 1950) 159: 279-289. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=9200464&retmode=ref&cmd=prlinks.
65. Tompa P (2002) Intrinsically unstructured proteins. Trends in Biochemical Sciences 27: 527-533. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/ elink.fcgi?dbfrom=pubmed&id=12368089&retmode=ref&cmd=prlinks.
66. Tompa P (2003) Intrinsically unstructured proteins evolve by repeat expansion. BioEssays 25: 847-855. Available: http://doi.wiley.com/10.1002/bies. 10324.
67. Blackman MJ (1990) A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. Journal of Experimental Medicine 172: 379-382. Available: http://www.jem.org/cgi/doi/10.1084/jem.172.1.379.
68. McBride JS, Heidrich HG (1987) Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Molecular and biochemical parasitology 23: 71-84. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=2437453&retmode=ref&cmd=prlinks.
69. Morgan WD, Lock MJ, Frenkiel TA, Grainger M, Holder AA (2004) Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR. Molecular and biochemical parasitology 138: 29-36. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=15500913&retmode=ref&cmd=prlinks.
70. Uthaipibull C, Aufiero B, Syed SEH, Hansen B, Patiño JAG, et al. (2001) Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. Journal of molecular biology 307: 1381-1394. Available: http://linkinghub.elsevier.com/retrieve/pii/ S0022283601945747.
71. Burgess BR, Schuck P, Garboczi DN (2005) Dissection of merozoite surface protein 3, a representative of a family of Plasmodium falciparum surface proteins, reveals an oligomeric and highly elongated molecule. The Journal of biological chemistry 280: 37236-37245. Available: http://eutils.ncbi.nlm.nih. gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=16135515&retmode= ref&cmd=prlinks.
72. Adda CG, Murphy VJ, Sunde M, Waddington LJ, Schloegel J, et al. (2009) Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils. Molecular and biochemical parasitology 166: 159-171. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=19450733&retmode=ref&cmd=prlinks.
73. Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31-40. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=3047011&retmode=ref&cmd=prlinks.
74. Khan F, Legler PM, Mease RM, Duncan EH, Bergmann-Leitner ES, et al. (2012) Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice. Biotechnology journal 7: 133-147. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 22076863&retmode=ref&cmd=prlinks.